Archived Newsletters

81. 11.03.25 -- STREAM Edition: Second Sourcing Is Natural ... Your Current CDMO Should Understand 11/3/2025

    11/03/25 Outsourced Pharma Newsletter

82. 11.03.25 -- A (Partial) Vindication For Wuxi AppTec … And Global Outsourcing 11/3/2025
    11/03/25 Outsourced Pharma Newsletter
83. 10.31.25 -- Consistent OOF Delivery Performance That Defines Manufacturing Reliability 10/31/2025

    10/31/25 Outsourced Pharma Newsletter

84. 10.31.25 -- Italy A Quiet Outsourcing Standout For Drug Manufacturing? 10/31/2025
    10/31/25 Outsourced Pharma Newsletter
85. 10.30.25 -- Advancing Cell & Gene Therapies: Inside Leading CDMO Innovations 10/30/2025
    10/30/25 Outsourced Pharma Newsletter
86. 10.30.25 -- Looking to outsource pDNA or mRNA process development? 10/30/2025

    10/30/25 Outsourced Pharma Newsletter

87. 10.30.25 -- Will It Not Die? The BIOSECURE Act Back With Iterations 10/30/2025
    10/30/25 Outsourced Pharma Newsletter
88. 10.29.25 -- Your Trusted Partners In Sterile Fill/Finish Manufacturing 10/29/2025
    10/29/25 Outsourced Pharma Newsletter
89. 10.29.25 -- Advancing Analytics In Biologics And Cell Therapy 10/29/2025

    10/29/25 Outsourced Pharma Newsletter

90. 10.29.25 -- Outsourcing: You Own It, They Earn It 10/29/2025
    10/29/25 Outsourced Pharma Newsletter